about
The mTOR pathway in obesity driven gastrointestinal cancers: Potential targets and clinical trialsMolecular predictive markers in tumors of the gastrointestinal tractPro-survival responses to the dual inhibition of anti-apoptotic Bcl-2 family proteins and mTOR-mediated signaling in hypoxic colorectal carcinoma cells4E-BP1, a multifactor regulated multifunctional proteinAssociation between obesity and local control of advanced rectal cancer after combined surgery and radiotherapy.Translationally controlled tumour protein TCTP is induced early in human colorectal tumours and contributes to the resistance of HCT116 colon cancer cells to 5-FU and oxaliplatin.Metformin inhibits proliferation and proinflammatory cytokines of human keratinocytes in vitro via mTOR-signaling pathway.Wnt Signaling in Normal and Malignant Stem Cells.Telomere length regulation through epidermal growth factor receptor signaling in cancer.Differences in metabolic biomarkers in the blood and gene expression profiles of peripheral blood mononuclear cells among normal weight, mildly obese and moderately obese subjects.Sex-dependent difference in the effect of metformin on colorectal cancer-specific mortality of diabetic colorectal cancer patients.Separation of low and high grade colon and rectum carcinoma by eukaryotic translation initiation factors 1, 5 and 6.Characterization of genetic intratumor heterogeneity in colorectal cancer and matching patient-derived spheroid cultures.MiR-489 suppresses tumor growth and invasion by targeting HDAC7 in colorectal cancer.Invitro Evaluation of Torin2 and 2, 6-Dihydroxyacetophenone in Colorectal Cancer Therapy.The Yeast Saccharomyces cerevisiae as a Model for Understanding RAS Proteins and their Role in Human Tumorigenesis.Targeting colorectal cancer cell metabolism through development of cisplatin and metformin nano-cubosomes
P2860
Q26751155-12D1E553-A411-4981-895E-3D602E470631Q28070583-BBB9C826-B693-4D82-B837-1A14DFFADBB8Q36086722-0A293DA7-F509-4017-81E9-15A632A070E3Q36838384-47050299-6D54-4816-BDD6-F0763887762CQ37079037-6C959247-1897-415F-89D8-919A5BBF12E4Q37618598-46A66AE4-182D-4757-97E7-6ED4B6A1D768Q38841006-15346575-63B3-4883-BE35-EE2A94C19886Q39306017-0B7E8DBD-F7D1-441C-A93D-2537F9BC0E34Q39455829-6A7D6F4F-4A79-43EC-AA9E-9CB2E606724FQ39511975-BEC9423A-909B-4FC5-85E6-914C9E3690ACQ41191101-A5658FB7-2E04-4E77-ACFF-90803C706218Q47280262-8D58CDB6-1A08-4E22-B18F-A85C089E2598Q47609470-E2F8ABA4-C17F-4B0B-9FE0-CB4D743E145FQ48126654-7D601FBA-1B92-4A7B-A31D-96BC88A6C927Q48364896-83719B3F-6520-406B-96EC-D7D9CFE0585DQ49798156-F36ACD7B-E77F-4CCA-B038-553E1105B688Q58778156-DE3B2A34-A735-4F3D-A3D0-37490C9E529D
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeting mTOR network in colorectal cancer therapy
@en
Targeting mTOR network in colorectal cancer therapy.
@nl
type
label
Targeting mTOR network in colorectal cancer therapy
@en
Targeting mTOR network in colorectal cancer therapy.
@nl
prefLabel
Targeting mTOR network in colorectal cancer therapy
@en
Targeting mTOR network in colorectal cancer therapy.
@nl
P2860
P356
P1476
Targeting mTOR network in colorectal cancer therapy
@en
P2093
Yan-Jie Zhang
P2860
P304
P356
10.3748/WJG.V20.I15.4178
P407
P50
P577
2014-04-01T00:00:00Z